FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1552409161> ?p ?o ?g. }

• W1552409161 endingPage "786" @default.
• W1552409161 startingPage "776" @default.
• W1552409161 abstract "Background The role of interleukin 2 (IL-2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post-liver transplant (LT) period is not well defined. Aim To examine the use of daclizumab induction in LT recipients with renal insufficiency. Methods Between 2002 and 2005, 62 patients (median pre-LT creatinine 2.4 mg/dL, IQR 1.9–3.7) received daclizumab induction with tacrolimus being administered when serum creatinine was <2.0 mg/dL. A concurrent comparison group (n = 221, 2002–2005) received tacrolimus-based immunosuppression without daclizumab (median pre-LT creatinine 1.1 mg/dL, IQR 0.9–1.4). A second historical comparison group (n = 103, 1995–2005) not receiving daclizumab was matched to the daclizumab patients by pre-LT serum creatinine (2.2 mg/dL, IQR 1.8–3.1). All patients received mycophenolate mofetil and steroids. Results Serum creatinine improved in the daclizumab group (−1.0 mg/dL, IQR −2.2 to −0.4) and worsened in the concurrent comparison group (+0.2 mg/dL, IQR 0–0.5) from pre-LT to 4 months. However, there was no difference when daclizumab group was compared with the historical comparison group matched on pre-LT creatinine (median change: −0.8 mg/dL vs. −0.7 mg/dL). Daclizumab induction was not associated with improvement in renal function at 4 months (P = 0.34) after adjusting for pre-LT creatinine, age, gender, hepatitis C status and simultaneous liver kidney transplantation. Conclusion The incremental benefit offered by induction therapy with IL-2 receptor antibodies to preserve renal function is questionable." @default.
• W1552409161 created "2016-06-24" @default.
• W1552409161 creator A5014433885 @default.
• W1552409161 creator A5019703929 @default.
• W1552409161 creator A5024309045 @default.
• W1552409161 creator A5041953810 @default.
• W1552409161 creator A5043249527 @default.
• W1552409161 creator A5055499310 @default.
• W1552409161 creator A5060169505 @default.
• W1552409161 creator A5065131065 @default.
• W1552409161 date "2010-07-26" @default.
• W1552409161 modified "2023-10-16" @default.
• W1552409161 title "Daclizumab induction therapy in liver transplant recipients with renal insufficiency" @default.
• W1552409161 cites W1975024520 @default.
• W1552409161 cites W1994839377 @default.
• W1552409161 cites W1998158725 @default.
• W1552409161 cites W2000110498 @default.
• W1552409161 cites W2011630864 @default.
• W1552409161 cites W2021543269 @default.
• W1552409161 cites W2022619332 @default.
• W1552409161 cites W2030553138 @default.
• W1552409161 cites W2034953095 @default.
• W1552409161 cites W2038811744 @default.
• W1552409161 cites W2055584277 @default.
• W1552409161 cites W2055598277 @default.
• W1552409161 cites W2074936215 @default.
• W1552409161 cites W2091921457 @default.
• W1552409161 cites W2093725163 @default.
• W1552409161 cites W2102882632 @default.
• W1552409161 cites W2117087522 @default.
• W1552409161 cites W2133275623 @default.
• W1552409161 cites W2134672034 @default.
• W1552409161 cites W2136041389 @default.
• W1552409161 cites W2142288396 @default.
• W1552409161 cites W2326669457 @default.
• W1552409161 doi "https://doi.org/10.1111/j.1365-2036.2010.04408.x" @default.
• W1552409161 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3606263" @default.
• W1552409161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20659283" @default.
• W1552409161 hasPublicationYear "2010" @default.
• W1552409161 type Work @default.
• W1552409161 sameAs 1552409161 @default.
• W1552409161 citedByCount "10" @default.
• W1552409161 countsByYear W15524091612012 @default.
• W1552409161 countsByYear W15524091612013 @default.
• W1552409161 countsByYear W15524091612016 @default.
• W1552409161 countsByYear W15524091612019 @default.
• W1552409161 crossrefType "journal-article" @default.
• W1552409161 hasAuthorship W1552409161A5014433885 @default.
• W1552409161 hasAuthorship W1552409161A5019703929 @default.
• W1552409161 hasAuthorship W1552409161A5024309045 @default.
• W1552409161 hasAuthorship W1552409161A5041953810 @default.
• W1552409161 hasAuthorship W1552409161A5043249527 @default.
• W1552409161 hasAuthorship W1552409161A5055499310 @default.
• W1552409161 hasAuthorship W1552409161A5060169505 @default.
• W1552409161 hasAuthorship W1552409161A5065131065 @default.
• W1552409161 hasBestOaLocation W15524091611 @default.
• W1552409161 hasConcept C126189478 @default.
• W1552409161 hasConcept C126322002 @default.
• W1552409161 hasConcept C126894567 @default.
• W1552409161 hasConcept C159641895 @default.
• W1552409161 hasConcept C2779609443 @default.
• W1552409161 hasConcept C2779719350 @default.
• W1552409161 hasConcept C2780091579 @default.
• W1552409161 hasConcept C2780252810 @default.
• W1552409161 hasConcept C2780306776 @default.
• W1552409161 hasConcept C2909675724 @default.
• W1552409161 hasConcept C2911091166 @default.
• W1552409161 hasConcept C71924100 @default.
• W1552409161 hasConcept C90924648 @default.
• W1552409161 hasConceptScore W1552409161C126189478 @default.
• W1552409161 hasConceptScore W1552409161C126322002 @default.
• W1552409161 hasConceptScore W1552409161C126894567 @default.
• W1552409161 hasConceptScore W1552409161C159641895 @default.
• W1552409161 hasConceptScore W1552409161C2779609443 @default.
• W1552409161 hasConceptScore W1552409161C2779719350 @default.
• W1552409161 hasConceptScore W1552409161C2780091579 @default.
• W1552409161 hasConceptScore W1552409161C2780252810 @default.
• W1552409161 hasConceptScore W1552409161C2780306776 @default.
• W1552409161 hasConceptScore W1552409161C2909675724 @default.
• W1552409161 hasConceptScore W1552409161C2911091166 @default.
• W1552409161 hasConceptScore W1552409161C71924100 @default.
• W1552409161 hasConceptScore W1552409161C90924648 @default.
• W1552409161 hasIssue "6" @default.
• W1552409161 hasLocation W15524091611 @default.
• W1552409161 hasLocation W15524091612 @default.
• W1552409161 hasLocation W15524091613 @default.
• W1552409161 hasLocation W15524091614 @default.
• W1552409161 hasOpenAccess W1552409161 @default.
• W1552409161 hasPrimaryLocation W15524091611 @default.
• W1552409161 hasRelatedWork W1969198220 @default.
• W1552409161 hasRelatedWork W1982197780 @default.
• W1552409161 hasRelatedWork W1984454075 @default.
• W1552409161 hasRelatedWork W2039925961 @default.
• W1552409161 hasRelatedWork W2057461145 @default.
• W1552409161 hasRelatedWork W2090639386 @default.
• W1552409161 hasRelatedWork W2133996490 @default.
• W1552409161 hasRelatedWork W2362687898 @default.
• W1552409161 hasRelatedWork W2379160126 @default.

• next